SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

30 Sep 2022 07:00

RNS Number : 2444B
Numis Corporation PLC
30 September 2022
 

30 September 2022

Numis Corporation Plc (Numis)

Trading update

 

Numis (LON: NUM), the international investment bank, today issues a trading update in respect of the year ending 30 September 2022.

Key highlights:

· Revenue for the full year is expected to be approximately £144m, representing a decline of around 33% compared to a record period in FY21

· Record advisory revenue performance reflects continued progress in diversifying the business; strong pipeline and the outlook for M&A revenues remains positive

· Uncertain global economic environment has caused capital markets activity to remain subdued throughout H2

· Following regulatory approval, Dublin office is operational and trading with a growing list of EU-based institutional clients

 

Strong M&A revenues partially offsets weaker capital markets performance

Investment banking revenues are expected to be approximately 39% lower than the prior year due to weaker capital markets revenues compared to a particularly strong 2021. Both public and private markets experienced a significant reduction in deal volumes year-on-year as investor sentiment continued to be impacted by the uncertain macro-economic outlook. However, this was partially offset by a record advisory revenue performance for the second successive year reflecting further progress against our long term objective to diversify our investment banking business.

 

Challenging market backdrop for equities clients

Equities revenues will be above £50m, but approximately 17% lower than the prior record year, with H2 revenue performance weaker than H1 due to lower institutional income. Our performance for the year reflects a challenging period for our institutional clients who have generally suffered outflows across UK focused funds resulting in lower trading volumes, particularly in mid-cap stocks. Following regulatory approval, our Dublin office is now operational and trading with a growing list of EU-based clients in line with our international strategy.

 

Outlook

Our near term M&A pipeline is strong and we are currently acting as financial adviser on nine announced public bids with an average transaction value of more than £1.5bn. However, the macro-economic and geo-political environment remain highly volatile and predicting the timing of any improvement in capital markets activity is very difficult. We remain committed to executing our long term corporate strategy to diversify our revenue streams which, combined with a strong balance sheet, supports our ability to deliver consistent returns to shareholders across the cycle. Consistent with previous periods of market volatility we will continue to invest in talent pursuant to our strategy.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018).

 

-ENDS -

 

Contacts:

 

Numis:

Noreen Biddle Shah, Head of Communications 020 7260 1441

 

FTI Consulting LLP:

Edward Bridges 07768 216607

Daisy Hall 07807 298568

Grant Thornton UK LLP (Nominated Adviser): Philip Secrett 020 7728 2578Harrison Clarke 020 7184 4384

 

 

About Numis

Numis (LON: NUM) is an international investment bank that partners with the most ambitious companies and investors, offering strategic advice, unique insights and connectivity to the capital markets.Already a leader in the UK market, Numis is the adviser of choice for listed companies, including one fifth of the FTSE 350 index and has acted on the most UK IPOs over the past decade.Since 2016, Numis has diversified its strategy to grow its UK M&A franchise, expand internationally and develop its private markets business.Founded in 1989, Numis is listed on London's AIM and has offices in London, New York, and Dublin.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKVNRUWUKUAR
Date   Source Headline
28th Mar 20223:59 pmRNSTransaction in Own Shares & Total Voting Rights
24th Mar 20223:48 pmRNSTransaction in Own Shares & Total Voting Rights
22nd Mar 20224:09 pmRNSTransaction in Own Shares & Total Voting Rights
18th Mar 20223:43 pmRNSTransaction in Own Shares & Total Voting Rights
18th Mar 202210:18 amRNSNotification of Major Holdings
17th Mar 20229:31 amRNSTransaction in Own Shares & Total Voting Rights
11th Mar 20223:36 pmRNSTransaction in Own Shares & Total Voting Rights
7th Mar 20224:47 pmRNSTransaction in Own Shares & Total Voting Rights
28th Feb 20225:02 pmRNSTransaction in Own Shares & Total Voting Rights
24th Feb 20227:00 amRNSBoard Change – Appointment of Independent NED
22nd Feb 20222:35 pmRNSTransaction in Own Shares & Total Voting Rights
10th Feb 202210:03 amRNSTransaction in Own Shares and Total Voting Rights
8th Feb 20221:13 pmRNSBoard Change
8th Feb 20221:12 pmRNS2022 Annual General Meeting ('AGM')
8th Feb 20227:00 amRNSAGM Trading Statement
7th Feb 20229:39 amRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20224:14 pmRNSHolding(s) in Company
1st Feb 20224:38 pmRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20224:00 pmRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20221:00 pmRNSDirectors’ Dealing
19th Jan 20227:00 amRNSGrant of awards under 2021 LTIP
14th Jan 20223:53 pmRNSTransaction in Own Shares and Total Voting Rights
10th Jan 20224:27 pmRNSTransaction in Own Shares and Total Voting RIghts
5th Jan 20227:00 amRNSAppointment of General Counsel & Company Secretary
4th Jan 20223:21 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20214:53 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Dec 20214:33 pmRNSTransaction in Own Shares and Total Voting Rights
21st Dec 20215:04 pmRNSTransaction in Own Shares and Total Voting Rights
20th Dec 20212:30 pmRNSAnnual Report and AGM Notice
20th Dec 202112:29 pmRNSReplacement Director's Dealing
20th Dec 202112:09 pmRNSHolding(s) in Company
17th Dec 202112:31 pmRNSDirector’s Dealing
15th Dec 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20217:00 amRNSFull Year Results for the year ended 30 Sep 2021
29th Nov 20214:58 pmRNSNotice of Final Results for the year ended 30 Sep
18th Nov 20214:03 pmRNSHolding(s) in Company
30th Sep 202112:32 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSTrading Update
17th Sep 20214:25 pmRNSTR-1: Notification of major holdings
13th Sep 20216:29 pmRNSTR-1: Notification of major holdings
13th Sep 20216:27 pmRNSTR-1: Notification of major holdings
13th Sep 202112:54 pmRNSTR-1: Notification of major holdings
13th Sep 202112:50 pmRNSTR-1: Notification of major holdings
1st Sep 20217:00 amRNSChange of Registered Office
10th Aug 20217:00 amRNSBoard Change
29th Jul 20216:07 pmRNSTR-1: Notification of major holdings
14th Jul 20217:00 amRNSTrading Update
14th May 20217:00 amEQSEdison Investment Research Limited: Numis Corporation (NUM): Very strong results, consistent strategy
7th May 20217:00 amRNSHalf Year Results
23rd Apr 20214:24 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.